MicrobiologyPLoS ONEPeer-reviewed
Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo
Yoji Tsugawa, Kentaro Furukawa, Tomoko Ise…·Satoshi Nagata
This study identifies an antibody, CV804, that targets the conserved S2 domain of coronaviruses and shows broad cross-reactivity and ADCC activity against SARS-CoV-2 and related viruses.
6 citations